NAFLD Patients have Limited Access to GLP1 Agonists and SGLT2 Inhibitors: NHANES-Transient Elastography 2017-2018
1. Abstract 1.1. Background and Aims: This study analyzed medications among NAFLD (controlled attenuation parameter ≥302 dB/m) ± diabetes or advanced fibrosis (AF, stiffness ≥9.7 kPa). 1.2. Method: 2017-2018 NHANES data were analyzed. Exclusion criteria were age<18, high alcohol consumption (≥7/14 drinks/week for females/males, respectively), or viral hepatitis. 1.3. Results: Of 3,899, 26.3% had NAFLD, …